2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$35.70+$0.09 (+0.24%)
Price as of Jun 23, 2026 7:51 PM EDT- $661.1MMarket Cap
- 89.60%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$35.70+$0.09 (+0.24%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.61 | ||
Change | +$2.82 (+8.57%) | ||
Open | $35.85 | ||
High | $36.50 | ||
Low | $35.55 | ||
Previous Close | $35.73 | ||
Volume | 257,674 | ||
30-Day Average Volume | 373,038 | ||
1-Week Change | 6.91% | ||
1-Month Change | 23.16% | ||
1-Year Change | 89.60% | ||
3-Year Change | 108.95% | ||
5-Year Change | -15.13% | ||
Fundamentals | |||
Shares Outstanding | 18.5M | ||
Total Assets | $504.6M | ||
Market Cap | $661.1M | ||
Enterprise Value | $681.5M | ||
Period: QTR TTM FY | |||
Revenue | $54.9M | ||
Net Income | $8.7M | ||
Free Cash Flow | -$7.3M | ||
EBIT | $11.9M | ||
EBITDA | $12.5M | ||
Net Working Capital | $144.5M | ||
EPS | $0.44 | ||
Enterprise Value/EBITDA | 55 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 2 | ||
P/E | 81 | ||
PEG | -1 | ||
Price/Free Cash Flow | -91 | ||
Price/Operating Cash Flow | 243 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue